Olive oil, honey, and seafood are among the most commonly faked foods, often mixed with cheaper ingredients or mislabeled to ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that data from the ongoing Phase 1b study of R2891, a potent and ...

St. Johnsbury School’s fifth-grade Olympians walked to the St. Johnsbury Police and Fire Stations on Oct. 28th to celebrate First Responder Appreciation Day. Students arrived with handmade posters, th ...

America once built supercars so wild they made Ferraris sweat - then forgot them faster than a C4 Corvette owner forgets ...

Science educators from across the region gathered last month at the Impact Career Innovation Center on the Durango High ...

Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma Two abstracts featuring new Phase 2 data highlight the potential of CAR ...

LUND, SE / ACCESS Newswire / November 3, 2025 / BioInvent International AB ("BioInvent") (STO:BINV), a biotech company focused on the discovery and development of novel and first-in-class ...

Additionally, the more than 50 abstracts accepted at ASH include new and updated data from Incyte’s MPN, GVHD and hematology ...

Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...

First grader Aizlynn Castillo works on an assignment in Diana Oviedo-Holguin’s English-learner class at Heritage Elementary ...

Computer science (CS) doesn’t have to be intimidating. With the right tools and support, any teacher can demystify coding and create meaningful CS learning. In this webinar, teachers and ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...